BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2645514)

  • 1. Enumeration of 6-thioguanine-resistant tumour cells using flow cytometry and comparison with a microtitration cloning assay.
    deFazio A; Heneine N; Musgrove EA; Tattersall MH
    Mutat Res; 1989 Feb; 216(1):57-64. PubMed ID: 2645514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric enumeration of drug-resistant tumor cells.
    deFazio A; Musgrove EA; Tattersall MH
    Cancer Res; 1988 Nov; 48(21):6037-43. PubMed ID: 3167854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forward mutation assay of V79 cells to 6-thioguanine resistance in a soft agar technique that eliminates effects of metabolic co-operation.
    Nishi Y; Hasegawa MM; Inui N
    Mutat Res; 1984 Jan; 125(1):105-14. PubMed ID: 6690909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A procedure for the CHO/HGPRT mutation assay involving treatment of cells in suspension culture and selection of mutants in soft-agar.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1987 Apr; 182(2):99-111. PubMed ID: 3561430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice.
    Aubrecht J; Goad ME; Schiestl RH
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1102-8. PubMed ID: 9262380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempts to use the HPRT-assay as an automated short-term monitor for an acute exposure to mutagens.
    Johannisson A; Eriksson B; Amnéus H; Zetterberg G
    Cell Biol Toxicol; 1992; 8(4):233-53. PubMed ID: 1493584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric determination of HPRT-variants in human peripheral blood lymphocytes.
    Kotova N; Grawé J
    Mutat Res; 2002 Jan; 499(1):63-71. PubMed ID: 11804605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of thioguanine-resistant lymphocytes from mice irradiated in vivo.
    Lorenz R; Göllner T; Hempel K
    Environ Health Perspect; 1990 Aug; 88():129-32. PubMed ID: 2272307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
    Albertini MR; King DM; Newton MA; Vacek PM
    Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of hypoxanthine-Guanine phosphoribosyltransferase short hairpin RNA confers chemoprotection against 6-thioguanine cytotoxicity.
    Hacke K; Treger JA; Bogan BT; Schiestl RH; Kasahara N
    Transplant Proc; 2013 Jun; 45(5):2040-4. PubMed ID: 23769104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene.
    Tates AD; van Dam FJ; de Zwart FA; van Teylingen CM; Natarajan AT
    Mutat Res; 1994 Sep; 309(2):299-306. PubMed ID: 7520989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of lung fibroblastic cell lines from a non-human primate Tupaia belangeri and their use in a forward gene mutation assay at the hypoxanthine-guanine phosphoribosyl transferase locus.
    Taketomi M; Nishi Y; Ohkawa Y; Inui N
    Mutagenesis; 1986 Sep; 1(5):359-65. PubMed ID: 3331674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals.
    Hou SM; Fält S; Steen AM
    Environ Mol Mutagen; 1995; 25(2):97-105. PubMed ID: 7698112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HAT- and HAsT-resistant HPRT mutant clones of V79 Chinese hamster cells.
    Zhang LH; Jenssen D
    Mutat Res; 1991 Jul; 263(3):151-8. PubMed ID: 1712425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of proliferating cells in vivo.
    deFazio A; Leary JA; Hedley DW; Tattersall MH
    J Histochem Cytochem; 1987 May; 35(5):571-7. PubMed ID: 3549891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for detecting somatic mutations in vitro: the human T-cell cloning assay selecting for HPRT mutants.
    Hou SM
    Methods Mol Biol; 2005; 291():155-60. PubMed ID: 15502220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect flow cytometric enumeration of 6-thioguanine-resistant human peripheral blood lymphocytes.
    Matsson P; Amnéus H; Djupsjöbacka M; Eriksson B; Eriksson L; Fellner-Feldegg H; Zetterberg G
    Cytometry; 1985 Nov; 6(6):648-56. PubMed ID: 4064844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes.
    Jones IM; Burkhart-Schultz K; Carrano AV
    Mutat Res; 1985 Jun; 147(3):97-105. PubMed ID: 3873611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of V79 cell clones with different phenotypes in aminopterin- or azaserine-containing media used for the selection of HGPRT revertants.
    Randazzo R; Bonatti S; Luccarini G; Abbondandolo A
    Mutat Res; 1984 May; 126(3):273-7. PubMed ID: 6717463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced proliferation rate of hypoxanthine-phosphoribosyl transferase mutant human T-lymphocytes in vitro.
    Podlutsky A; Bastlová T; Lambert B
    Environ Mol Mutagen; 1996; 28(1):13-8. PubMed ID: 8698041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.